These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15777262)

  • 41. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A tertiary twist to the transglutaminase tale.
    Koning F
    PLoS Biol; 2007 Dec; 5(12):e337. PubMed ID: 18162046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of transglutaminase protein substrates by functional proteomics.
    Ruoppolo M; Orrù S; D'Amato A; Francese S; Rovero P; Marino G; Esposito C
    Protein Sci; 2003 Jun; 12(6):1290-7. PubMed ID: 12761400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.
    Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS
    Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses.
    D'Eletto M; Farrace MG; Piacentini M; Rossin F
    Methods Enzymol; 2017; 587():511-520. PubMed ID: 28253975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
    Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
    Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a mechanism-based assay for tissue transglutaminase--results of a high-throughput screen and discovery of inhibitors.
    Case A; Ni J; Yeh LA; Stein RL
    Anal Biochem; 2005 Mar; 338(2):237-44. PubMed ID: 15745743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evolutionary-biological peculiarities of transglutaminase. Structure, physiological functions, application].
    Shleĭkin AG; Danilov NP
    Zh Evol Biokhim Fiziol; 2011; 47(1):3-14. PubMed ID: 21469335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification and partial characterization of 76 kDa transglutaminase in the egg envelope (chorion) of rainbow trout, Oncorhynchus mykiss.
    Ha CR; Iuchi I
    J Biochem; 1997 Nov; 122(5):947-54. PubMed ID: 9443809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transglutaminases: purification and activity assays.
    Wilhelm B; Meinhardt A; Seitz J
    J Chromatogr B Biomed Appl; 1996 Sep; 684(1-2):163-77. PubMed ID: 8906472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
    Iannaccone M; Titta F; Serretiello E; Monfregola M; Gentile V
    Recent Pat CNS Drug Discov; 2014; 9(2):76-84. PubMed ID: 25386917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyamines and transglutaminase actions.
    Romijn JC
    Andrologia; 1990; 22 Suppl 1():83-91. PubMed ID: 1983418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leishmania species: evidence for transglutaminase activity and its role in parasite proliferation.
    Brobey RK; Soong L
    Exp Parasitol; 2006 Oct; 114(2):94-102. PubMed ID: 16620812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A specific colorimetric assay for measuring transglutaminase 1 and factor XIII activities.
    Hitomi K; Kitamura M; Alea MP; Ceylan I; Thomas V; El Alaoui S
    Anal Biochem; 2009 Nov; 394(2):281-3. PubMed ID: 19646949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
    Grosso H; Mouradian MM
    Pharmacol Ther; 2012 Mar; 133(3):392-410. PubMed ID: 22212614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.
    Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K
    FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel transglutaminase-catalyzed posttranslational modification of HIV-1 aspartyl protease.
    Beninati S; Mukherjee AB
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1211-8. PubMed ID: 1358064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cross-linking in an artificial human cornea via induction of tissue transglutaminases].
    Kopsachilis N; Tsinopoulos I; Tsaousis KT; Meiller R; Dimitrakos SA; Kruse FE; Luessen UW
    Ophthalmologe; 2012 Jun; 109(6):583-90. PubMed ID: 22526004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase).
    Matsuki M; Yamashita F; Ishida-Yamamoto A; Yamada K; Kinoshita C; Fushiki S; Ueda E; Morishima Y; Tabata K; Yasuno H; Hashida M; Iizuka H; Ikawa M; Okabe M; Kondoh G; Kinoshita T; Takeda J; Yamanishi K
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1044-9. PubMed ID: 9448282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transglutaminase 2 in neurodegenerative disorders.
    Ruan Q; Johnson GV
    Front Biosci; 2007 Jan; 12():891-904. PubMed ID: 17127346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.